Surface Oncology, Inc. posts $-63.59 million annual loss

Surface Oncology, Inc. [SURF]  has posted annual loss of $-63.59 million for the year ended Dec 31,2022.

The company based in Massachusetts(MA)reported a risein revenue to $30 milion for the year when compared to $2.69 million in the previous year.

A filing from the company with the Securities and Exchange Commission on Mar 9,2023 showed that its revenue is  up 1016.49% year-over-year.

The company reported basic earnings per share of $55761386 and diluted earnings per share of $55761386.

Surface Oncology, Inc. operates in the Biological Products, Except Diagnostic Substances sector.